US20020007106A1 - Intra-viginal device - Google Patents

Intra-viginal device Download PDF

Info

Publication number
US20020007106A1
US20020007106A1 US09/197,736 US19773698A US2002007106A1 US 20020007106 A1 US20020007106 A1 US 20020007106A1 US 19773698 A US19773698 A US 19773698A US 2002007106 A1 US2002007106 A1 US 2002007106A1
Authority
US
United States
Prior art keywords
base
vaginal wall
back portion
posterior
urethra
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US09/197,736
Other versions
US6413206B2 (en
Inventor
Nicholas Biswas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Niquoola Pty Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/AU1997/000186 external-priority patent/WO1997034550A1/en
Priority claimed from AUPO8796A external-priority patent/AUPO879697A0/en
Priority claimed from AUPO9323A external-priority patent/AUPO932397A0/en
Application filed by Individual filed Critical Individual
Assigned to NIQUOOLA PTY LTD reassignment NIQUOOLA PTY LTD ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BISWAS, NICHOLAS
Publication of US20020007106A1 publication Critical patent/US20020007106A1/en
Application granted granted Critical
Publication of US6413206B2 publication Critical patent/US6413206B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0004Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
    • A61F2/0031Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra
    • A61F2/005Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra with pressure applied to urethra by an element placed in the vagina

Definitions

  • the present invention relates to intra-vaginal devices to aid in controlling urinary incontinence.
  • U.S. Pat. No. 4,139,006 Disclosed in U.S. Pat. No. 4,139,006 is an intra-vaginal device for controlling urinary incontinence in female patients.
  • the device is slightly arcuate so as to have slightly raised anterior and posterior vaginal wall engaging portions with a lower central aperture.
  • the anterior portion has a pair of projections generally within the plane of the device which engage the vaginal wall to apply pressure to the urethra, to close the urethra.
  • U.S. Pat. Nos. 5,036,867 and 4,920,986 also disclose intra-vaginal devices to aid in controlling urinary incontinence. However, these devices are arcuate in the opposite direction tot he previous device and engage the anterior vaginal wall to cradle the bladder neck. The urethra is not closed.
  • U.S. Pat. No. 4,920,986 discloses a modification of the previous two devices but again the device cradles the bladder neck.
  • an intra-vaginal device to aid in controlling urinary incontinence comprising:
  • a base to extend between the anterior vaginal wall and the posterior vaginal wall of a patient, so as to apply pressure thereto, said base having a forward convex surface to engage the anterior vaginal wall to support and elevate the anterior vaginal wall and urethra without occluding the urethra, and a rear part to engage the posterior vaginal wall;
  • a back portion extending from said rear part so that in use it extends therefrom towards the cervix and is supported on the pelvic floor so as to distribute the pressure applied to the posterior wall.
  • FIG. 1 is a schematic perspective view of an intra-vaginal device to aid in controlling urinary incontinence
  • FIG. 2 is a schematic top plan view of the device of FIG. 1; 2 .
  • FIG. 3 is a schematic end elevation of the device of FIG. 1;
  • FIG. 4 is a schematic side elevation of the device of FIG. 1;
  • FIG. 5 is a schematic perspective view of a modified form of the device of FIG. 1;
  • FIG. 6 is a schematic top plan view of the device of FIG. 5;
  • FIG. 7 is a schematic end elevation of the device of FIG. 5;
  • FIG. 8 is a schematic side elevation of the device of FIG. 5;
  • FIG. 9 is a schematic perspective view of a further device to aid in controlling urinary incontinence
  • FIG. 10 is a schematic side elevation of the device of FIG. 9;
  • FIG. 11 is a schematic top plan view of the device of FIG. 9;
  • FIG. 12 is a schematic end elevation of the device of FIG. 9;
  • FIG. 13 is a schematic perspective view of a modified form of the device of FIG. 9;
  • FIG. 14 is a schematic side elevation of the device of FIG. 13;
  • FIG. 15 is a schematic top plan view of the device of FIG. 13;
  • FIG. 16 is a schematic end elevation of the device of FIG. 13;
  • FIG. 17 is a sagital abdominal cross-sectional view of a female patient illustrating the normal physiology of the bladder and urethra;
  • FIG. 18 is a sagital abdominal cross-sectional view of an incontinent female patient with the bladder neck in a descended position
  • FIG. 19 is a sagital abdominal cross-sectional view of the female patient of
  • FIG. 18 showing the device of FIGS. 13 to 16 installed. 3 .
  • FIGS. 1 to 8 of the accompanying drawings there is schematically depicted two intra-vaginal devices 30 to aid in controlling urinary incontinence.
  • the devices 30 each include a base 31 having a forward arcuate part 32 with a forward convex surface 33 which engages the anterior wall to support and elevate the anterior vaginal wall and the urethra behind the vaginal wall. In that regard it should be appreciated that the devices 30 do not close the urethra.
  • the base 31 is generally of a toroidal configuration and provides a rear part 34 and a central aperture 35 .
  • a back portion 36 Extending generally normal (that is at a slight inclination) to the base 31 and from the rear part 34 is a back portion 36 which is also generally of a toroidal configuration and has a central aperture 37 .
  • the base 31 and back portion 36 define a slightly obtuse included angle.
  • the back portion 36 engages the posterior vaginal wall and is supported by the pelvic floor and projects generally toward the cervix from the base 31 .
  • the base 31 extends between the posterior and anterior vaginal walls to apply supporting pressure thereto. The pressure applied to the posterior vaginal wall is distributed over the back portion 36 .
  • the devices 30 would be formed of a resilient plastics material.
  • FIGS. 1 to 8 The above described preferred embodiments described with reference to FIGS. 1 to 8 is particularly suited for use by women with incontinence and prolapse with a poor pelvic floor.
  • the surface 33 is not only convex as a result of consisting of a curve extending about the center of the aperture 35 (as best seen in FIG. 7) but may also be convex in a plane generally perpendicular thereto as best seen in the cross section of FIG. 8.
  • the base 31 has a length 48 of between 35 mm and 55 mm, preferably within the range of 40 mm to 50 mm.
  • the base 31 should also have a depth 49 of 1 to 3 cm, preferably 1.5 to 2.5 cm.
  • the base 31 should have a thickness 50 of 3 to 6 mm, preferably 4 to 5 mm.
  • FIGS. 9 to 16 of the accompanying drawings there are schematically depicted intra-vaginal devices 40 to aid in controlling urinary incontinence.
  • Each device 40 has a base 41 provided with an arcuate forward part 42 .
  • the part 42 has a convex surface 43 which applies pressure to the anterior vaginal wall to support the vaginal wall and urethra therebehind.
  • the base 31 is of a toroidal configuration having a central aperture 45 .
  • a back portion 46 Projecting generally normal from the base 41 is a back portion 46 which is generally “oval” in configuration. That is it has elongated sides terminating with an upper arcuate portion.
  • the back portion 46 has a central slot 47 .
  • the base 41 is slightly inclined to the back portion 46 .
  • the base 41 extends between the anterior and posterior vaginal walls to apply pressure thereto.
  • the pressure applied to the posterior vaginal wall is distributed over the back portion 46 .
  • the back portion 46 projects towards the cervix and is supported by the pelvic floor. 5 .
  • the device of FIGS. 9 to 16 is suitable for younger women with prolapse and urinary incontinence.
  • the surface 43 is not only convex as a result of consisting of a curve extending about the center of the aperture 35 (as best seen in FIG. 15) but may also be convex in a plane generally perpendicular thereto as best seen in FIG. 14.
  • the base 41 has a length 48 of between 35 mm and 55 mm, preferably within the range of 40 mm to 50 mm.
  • the base 41 should also have a depth 49 of 1 to 3 cm, preferably 1.5 to 2.5 cm.
  • the base 41 should have a thickness 50 of 3 to 6 mm, preferably 4 to 5 mm.
  • the rear surface 44 is also provided with an enlarged part 51 which is formed by shaping the rear surface 44 so as to be convex when viewed in side elevation (as best seen in FIG. 14).
  • the rear surface 44 which engage the rear posterior vaginal wall, is also arcuate so as to be convex in a plane normal to the back portion 46 .
  • the above two described embodiments address the surfaces 33 and 43 apply pressure to the anterior vaginal wall adjacent the urethra so as to support and elevate the anterior vaginal wall and urethra located therebehind. This support and elevation occurs without occluding the urethra.
  • the dimensions 48 and 49 are arranged such that the force applied to 6 . the anterior vaginal wall is distributed to the extend that the urethra is not occluded but merely elevated and supported.
  • FIG. 17 illustrates the normal anatomy of the urinary system of a female patient. Shown in FIG. 17 are the symphysis pubis 60 ; bladder 62 with bladder neck 64 ; urethra 66 ; pelvic floor 68 ; vagina 70 with anterior vaginal wall 72 and posterior vaginal wall 74 ; and uterus 76 . Above the pelvic floor 68 is the abdominal cavity 78 , with the vaginal cavity 80 lying below the pelvic floor.
  • FIG. 17 is the position of the bladder neck 64 .
  • the bladder 62 is located such that the bladder neck 64 is positioned above the pelvic floor 68 .
  • the upper portion 84 of the urethra 66 lies within the abdominal cavity 78
  • the lower portion 86 of the urethra lies within the vaginal cavity 80 .
  • This transient pressure on the upper portion 84 of the urethra 66 balances the pressure exerted on the bladder 62 and thus helps prevent the leakage of urine despite transient increased bladder pressure.
  • the bladder neck 64 has descended to a location at or below the pelvic floor 68 .
  • the entire urethra 66 lies within the vaginal cavity 80 .
  • condition illustrated in FIG. 18 can be either a static condition, such as when a cystocele condition exists, or a dynamic condition, which exists only in response to increased abdominal pressure.
  • a static condition such as when a cystocele condition exists
  • a dynamic condition which exists only in response to increased abdominal pressure.
  • the normal position of the bladder neck 64 in the absence of increased abdominal pressure may resemble that shown in FIG. 18.
  • the bladder neck 64 will momentarily descend to a location at or below the pelvic floor 68 , with the urine leakage consequences described above.
  • FIG. 19 shows the device 40 installed to correct improper position of the urethra 66 . While the figures show the use of the device 40 , it is to be understood that the device 30 is installed and functions in the same general manner as to the device 40 .
  • the back portion 46 of the device 40 rests on the posterior vaginal wall 74 .
  • the length and configuration of the back portion 46 of the device prevents the device from rotating or otherwise becoming displaced within the vagina 70 .
  • the lower end of the device 40 rests on the pelvic floor 68 .
  • the convex forward surface 43 of the base 41 of the device displaces the anterior vaginal wall 72 forward and upward to support the urethra 66 .
  • This support stabilises a hypermobile urethra such that the upper portion 84 of the urethra 66 is retained within the abdominal cavity 78 . Consequently, when a dynamic abdominal pressure is exerted, a portion of the abdominal pressure is applied against the upper portion 84 of the urethra 66 , which provides an additional force to offset transient 8 . bladder pressure increases.
  • a device 40 in which the base 41 has a length 48 (see FIG. 14) of 35-55 millimeters, and most often 40-50 millimeters will elevate the anterior wall 72 of the vagina 70 sufficiently to support the urethra 66 in the desired position.
  • the length 48 of the device 40 needed to accomplish this result will depend on the physiology of the particular female patient, such that devices having a height of greater than 55 millimeters or less than 35 millimeters may be necessary to elevate the anterior vaginal wall 72 to support the urethra 66 in the proper position without occluding it.
  • the purpose of the devices 30 , 40 is to support the urethra 66 without occluding it. Since exerting a force at single point along the length of the urethra 66 tends to have an occlusive effect, it is desirable to spread the support along a length of the urethra. Since the length of the urethra 66 of an adult female tends to be approximately 3 centimeters, an effective depth 49 (FIG. 14) for the convex forward end 43 of the base 41 of the device 40 has been found to be approximately 2.5 centimeters.
  • a device 30 , 40 having a forward edge 43 with a depth of as little as 1 centimeter may produce acceptable results, so long as the effect of the supporting edge is to elevate the urethra to a retropubic intra-abdominal position without occluding it. 9 .

Abstract

An intra-vaginal device (30) to aid in controlling urinary incontinence. The device (30) has a base (31) from which there projects a rear part (34). The rear part (34) engages the posterior vaginal wall and rests on the pelvic floor and projects towards the cervix. The base (31) has a convex surface (33) which engages the anterior vaginal wall to support the vaginal wall and the urethra therebehind.

Description

  • This is a continuation of International Application No. PCT/AU98/00183, filed Mar. 20,1998, the disclosure of which is incorporated herein by reference, which relies for priority on International Application No. PCT/AU97/00186, filed Mar. 20, 1997, Australian Provisional Application No. P08796, filed Aug. 27,1997 and Australian Provisional Application No. P09323, filed Sep. 19,1997. [0001]
  • TECHNICAL FIELD
  • The present invention relates to intra-vaginal devices to aid in controlling urinary incontinence. [0002]
  • BACKGROUND OF THE INVENTION
  • Disclosed in U.S. Pat. No. 4,139,006 is an intra-vaginal device for controlling urinary incontinence in female patients. The device is slightly arcuate so as to have slightly raised anterior and posterior vaginal wall engaging portions with a lower central aperture. The anterior portion has a pair of projections generally within the plane of the device which engage the vaginal wall to apply pressure to the urethra, to close the urethra. U.S. Pat. Nos. 5,036,867 and 4,920,986 also disclose intra-vaginal devices to aid in controlling urinary incontinence. However, these devices are arcuate in the opposite direction tot he previous device and engage the anterior vaginal wall to cradle the bladder neck. The urethra is not closed. U.S. Pat. No. 4,920,986 discloses a modification of the previous two devices but again the device cradles the bladder neck. [0003]
  • OBJECT OF THE INVENTION
  • It is the object of the present invention to at least partly correct hypermobility and augment urethrae support. [0004]
  • SUMMARY OF THE INVENTION
  • There is disclosed herein an intra-vaginal device to aid in controlling urinary incontinence, said device comprising: [0005]
  • a base to extend between the anterior vaginal wall and the posterior vaginal wall of a patient, so as to apply pressure thereto, said base having a forward convex surface to engage the anterior vaginal wall to support and elevate the anterior vaginal wall and urethra without occluding the urethra, and a rear part to engage the posterior vaginal wall; and [0006]
  • a back portion extending from said rear part so that in use it extends therefrom towards the cervix and is supported on the pelvic floor so as to distribute the pressure applied to the posterior wall.[0007]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • A preferred form of the present invention will now be described by way of example with reference to the accompanying drawings wherein: [0008]
  • FIG. 1 is a schematic perspective view of an intra-vaginal device to aid in controlling urinary incontinence; [0009]
  • FIG. 2 is a schematic top plan view of the device of FIG. 1; [0010] 2.
  • FIG. 3 is a schematic end elevation of the device of FIG. 1; [0011]
  • FIG. 4 is a schematic side elevation of the device of FIG. 1; [0012]
  • FIG. 5 is a schematic perspective view of a modified form of the device of FIG. 1; [0013]
  • FIG. 6 is a schematic top plan view of the device of FIG. 5; [0014]
  • FIG. 7 is a schematic end elevation of the device of FIG. 5; [0015]
  • FIG. 8 is a schematic side elevation of the device of FIG. 5; [0016]
  • FIG. 9 is a schematic perspective view of a further device to aid in controlling urinary incontinence; [0017]
  • FIG. 10 is a schematic side elevation of the device of FIG. 9; [0018]
  • FIG. 11 is a schematic top plan view of the device of FIG. 9; [0019]
  • FIG. 12 is a schematic end elevation of the device of FIG. 9; [0020]
  • FIG. 13 is a schematic perspective view of a modified form of the device of FIG. 9; [0021]
  • FIG. 14 is a schematic side elevation of the device of FIG. 13; [0022]
  • FIG. 15 is a schematic top plan view of the device of FIG. 13; [0023]
  • FIG. 16 is a schematic end elevation of the device of FIG. 13; [0024]
  • FIG. 17 is a sagital abdominal cross-sectional view of a female patient illustrating the normal physiology of the bladder and urethra; [0025]
  • FIG. 18 is a sagital abdominal cross-sectional view of an incontinent female patient with the bladder neck in a descended position; and [0026]
  • FIG. 19 is a sagital abdominal cross-sectional view of the female patient of [0027]
  • FIG. 18 showing the device of FIGS. [0028] 13 to 16 installed. 3.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • The following embodiments are modifications and/or improvements in the devices described in international Application PCT/AU97/00186. [0029]
  • In FIGS. [0030] 1 to 8 of the accompanying drawings there is schematically depicted two intra-vaginal devices 30 to aid in controlling urinary incontinence. The devices 30 each include a base 31 having a forward arcuate part 32 with a forward convex surface 33 which engages the anterior wall to support and elevate the anterior vaginal wall and the urethra behind the vaginal wall. In that regard it should be appreciated that the devices 30 do not close the urethra. The base 31 is generally of a toroidal configuration and provides a rear part 34 and a central aperture 35.
  • Extending generally normal (that is at a slight inclination) to the [0031] base 31 and from the rear part 34 is a back portion 36 which is also generally of a toroidal configuration and has a central aperture 37. The base 31 and back portion 36 define a slightly obtuse included angle. In use, the back portion 36 engages the posterior vaginal wall and is supported by the pelvic floor and projects generally toward the cervix from the base 31. The base 31 extends between the posterior and anterior vaginal walls to apply supporting pressure thereto. The pressure applied to the posterior vaginal wall is distributed over the back portion 36.
  • Preferably the [0032] devices 30 would be formed of a resilient plastics material.
  • The above described preferred embodiments described with reference to FIGS. [0033] 1 to 8 is particularly suited for use by women with incontinence and prolapse with a poor pelvic floor.
  • With reference to the preferred embodiment of FIGS. [0034] 5 to 8, it should be appreciated that the surface 33 is not only convex as a result of consisting of a curve extending about the center of the aperture 35 (as best seen in FIG. 7) but may also be convex in a plane generally perpendicular thereto as best seen in the cross section of FIG. 8.
  • The [0035] base 31 has a length 48 of between 35 mm and 55 mm, preferably within the range of 40 mm to 50 mm. The base 31 should also have a depth 49 of 1 to 3 cm, preferably 1.5 to 2.5 cm. Still further, the base 31 should have a thickness 50 of 3 to 6 mm, preferably 4 to 5 mm.
  • In FIGS. [0036] 9 to 16 of the accompanying drawings there are schematically depicted intra-vaginal devices 40 to aid in controlling urinary incontinence. Each device 40 has a base 41 provided with an arcuate forward part 42. The part 42 has a convex surface 43 which applies pressure to the anterior vaginal wall to support the vaginal wall and urethra therebehind. The base 31 is of a toroidal configuration having a central aperture 45.
  • Projecting generally normal from the [0037] base 41 is a back portion 46 which is generally “oval” in configuration. That is it has elongated sides terminating with an upper arcuate portion. The back portion 46 has a central slot 47. Again, the base 41 is slightly inclined to the back portion 46.
  • The [0038] base 41 extends between the anterior and posterior vaginal walls to apply pressure thereto. The pressure applied to the posterior vaginal wall is distributed over the back portion 46. The back portion 46 projects towards the cervix and is supported by the pelvic floor. 5.
  • The device of FIGS. [0039] 9 to 16 is suitable for younger women with prolapse and urinary incontinence. Preferably it would be formed of an absorbent material so that it could also act as a tampon.
  • It should be appreciated in the embodiment of FIGS. [0040] 13 to 16 that the surface 43 is not only convex as a result of consisting of a curve extending about the center of the aperture 35 (as best seen in FIG. 15) but may also be convex in a plane generally perpendicular thereto as best seen in FIG. 14.
  • The [0041] base 41 has a length 48 of between 35 mm and 55 mm, preferably within the range of 40 mm to 50 mm. The base 41 should also have a depth 49 of 1 to 3 cm, preferably 1.5 to 2.5 cm. Still further, the base 41 should have a thickness 50 of 3 to 6 mm, preferably 4 to 5 mm.
  • The [0042] rear surface 44 is also provided with an enlarged part 51 which is formed by shaping the rear surface 44 so as to be convex when viewed in side elevation (as best seen in FIG. 14). The rear surface 44, which engage the rear posterior vaginal wall, is also arcuate so as to be convex in a plane normal to the back portion 46.
  • The above two described embodiments address urinary incontinence problems previously ameliorated by urethra pexy or sling procedure. [0043]
  • The above two described embodiments address the [0044] surfaces 33 and 43 apply pressure to the anterior vaginal wall adjacent the urethra so as to support and elevate the anterior vaginal wall and urethra located therebehind. This support and elevation occurs without occluding the urethra. In the above described two embodiments the dimensions 48 and 49 are arranged such that the force applied to 6. the anterior vaginal wall is distributed to the extend that the urethra is not occluded but merely elevated and supported.
  • FIG. 17 illustrates the normal anatomy of the urinary system of a female patient. Shown in FIG. 17 are the [0045] symphysis pubis 60; bladder 62 with bladder neck 64; urethra 66; pelvic floor 68; vagina 70 with anterior vaginal wall 72 and posterior vaginal wall 74; and uterus 76. Above the pelvic floor 68 is the abdominal cavity 78, with the vaginal cavity 80 lying below the pelvic floor.
  • Of particular note in FIG. 17 is the position of the [0046] bladder neck 64. The bladder 62 is located such that the bladder neck 64 is positioned above the pelvic floor 68. The upper portion 84 of the urethra 66 lies within the abdominal cavity 78, and the lower portion 86 of the urethra lies within the vaginal cavity 80. As a consequence of the upper portion 84 of the urethra 66 lying within the abdominal cavity 78, when dynamic abdominal pressure is exerted, such as by exercise or by coughing, the abdominal pressure is exerted not only-on the bladder 62 but also on the upper portion 84 of the urethra 66. This transient pressure on the upper portion 84 of the urethra 66 balances the pressure exerted on the bladder 62 and thus helps prevent the leakage of urine despite transient increased bladder pressure.
  • In FIG. 18, the [0047] bladder neck 64 has descended to a location at or below the pelvic floor 68. The entire urethra 66 lies within the vaginal cavity 80. In this condition, when dynamic abdominal pressure is exerted, because the upper portion 84 of the urethra 66 no longer lies within the abdominal cavity 78, there is no increased pressure exerted on the urethra 66 to offset the transient increased bladder pressure. Consequently, urine will leak when dynamic abdominal pressure 7. is exerted, a condition known as stress urinary incontinence.
  • It will be appreciated that the condition illustrated in FIG. 18 can be either a static condition, such as when a cystocele condition exists, or a dynamic condition, which exists only in response to increased abdominal pressure. In a patient suffering the latter condition, the normal position of the [0048] bladder neck 64 in the absence of increased abdominal pressure may resemble that shown in FIG. 18. However, because of inadequate support, under increased abdominal pressure the bladder neck 64 will momentarily descend to a location at or below the pelvic floor 68, with the urine leakage consequences described above.
  • FIG. 19 shows the [0049] device 40 installed to correct improper position of the urethra 66. While the figures show the use of the device 40, it is to be understood that the device 30 is installed and functions in the same general manner as to the device 40.
  • The [0050] back portion 46 of the device 40 rests on the posterior vaginal wall 74. The length and configuration of the back portion 46 of the device prevents the device from rotating or otherwise becoming displaced within the vagina 70. The lower end of the device 40 rests on the pelvic floor 68. With the device 40 installed in this position, the convex forward surface 43 of the base 41 of the device displaces the anterior vaginal wall 72 forward and upward to support the urethra 66. This support stabilises a hypermobile urethra such that the upper portion 84 of the urethra 66 is retained within the abdominal cavity 78. Consequently, when a dynamic abdominal pressure is exerted, a portion of the abdominal pressure is applied against the upper portion 84 of the urethra 66, which provides an additional force to offset transient 8. bladder pressure increases.
  • In most adult female patients, it has been found that a [0051] device 40 in which the base 41 has a length 48 (see FIG. 14) of 35-55 millimeters, and most often 40-50 millimeters, will elevate the anterior wall 72 of the vagina 70 sufficiently to support the urethra 66 in the desired position. However, it will be appreciated that the length 48 of the device 40 needed to accomplish this result will depend on the physiology of the particular female patient, such that devices having a height of greater than 55 millimeters or less than 35 millimeters may be necessary to elevate the anterior vaginal wall 72 to support the urethra 66 in the proper position without occluding it. so long as the upper portion 84 of the urethra 66 is supported above the anterior segment of the pelvic floor 68 in a retropubic intra-abdominal position, continence should be achieved, thereby correcting hypermobility and augmenting urethrae support.
  • As will be appreciated, the purpose of the [0052] devices 30, 40 is to support the urethra 66 without occluding it. Since exerting a force at single point along the length of the urethra 66 tends to have an occlusive effect, it is desirable to spread the support along a length of the urethra. Since the length of the urethra 66 of an adult female tends to be approximately 3 centimeters, an effective depth 49 (FIG. 14) for the convex forward end 43 of the base 41 of the device 40 has been found to be approximately 2.5 centimeters. However, it will be appreciated that a device 30, 40 having a forward edge 43 with a depth of as little as 1 centimeter may produce acceptable results, so long as the effect of the supporting edge is to elevate the urethra to a retropubic intra-abdominal position without occluding it. 9.

Claims (17)

What is claimed is:
1. An intra-vaginal device to aid in controlling urinary incontinence, said device comprising:
a base to extend between the anterior vaginal wall and the posterior vaginal wall of a patient, so as to apply pressure thereto, said base having a forward convex surface to engage the anterior vaginal wall to support and elevate the anterior vaginal wall and urethra, and a rear part to engage the posterior vaginal wall; and
a back portion extending from said rear part so that in use it extends therefrom towards the cervix and is supported on the pelvic floor so as to distribute the pressure applied to the posterior wall.
2. The device of claim 1, wherein said base is generally toroidal in configuration so as to have a central aperture.
3. The device of claim 1, wherein the back portion is inclined to the base so as to define an included obtuse angle slightly larger than 90°.
4. The device of claim 1, wherein the forward convex surface is arcuate both within the plane of the base and a plane generally perpendicular to the base.
5. The device of claim 4, wherein said back portion has a central slot.
6. The device of claim 1, wherein said back part is generally of a toroidal configuration having a central aperture.
7. The device of claim 1, wherein said back portion has elongated sides extending from the base, which sides extend to an arcuate extremity.
8. The device of claim 7, wherein said back portion has a surface to engage the posterior vaginal wall, which surface is arcuate so as to be convex in a plane normal to the back portion.
9. The device of claim 7, wherein said back portion has an enlarged part which projects toward the posterior vaginal wall.
10. The device of claim 1 formed of resilient plastics material.
11. The device of claim 1 formed of an absorbent material so as to act as a tampon.
12. An intra-vaginal device to aid in controlling urinary incontinence, said device comprising:
a base to extend between the anterior vaginal wall and the posterior vaginal wall of a patient, so as to apply pressure thereto, said base having a forward convex surface to engage the anterior vaginal wall to support and elevate the anterior vaginal wall and urethra, and a rear part to engage the posterior vaginal wall; and
a back portion extending from said rear part so that in use it extends therefrom towards the cervix and is supported on the pelvic floor so as to distribute the pressure applied to the posterior wall, the back portion being inclined to the base so as to define an inclined obtuse angle slightly larger than 90° and wherein the forward convex surface is arcuate both within the plane of the base and a plane generally perpendicular to the base.
13. The device of claim 12, wherein said base includes a central aperture and is generally toroidal in configuration and said back part includes a back central aperture and is generally of a toroidal configuration.
14. The device of claim 12, wherein said back portion has elongated sides extending from the base, which sides extend to an arcuate extremity.
15. The device of claim 14, wherein said back portion has a surface to engage the posterior vaginal wall, which surface is arcuate so as to be convex in a plane normal to the back portion.
16. The device of claim 15, wherein said back portion has an enlarged part which projects toward the posterior vaginal wall.
17. The device of claim 12 formed of an absorbent material. 12.
US09/197,736 1997-03-20 1998-11-20 Intra-vaginal device Expired - Fee Related US6413206B2 (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
PCT/AU1997/000186 WO1997034550A1 (en) 1996-03-20 1997-03-20 An intra-vaginal device
USPCTAU9700186 1997-03-20
AUP08796 1997-08-27
AUPO8796A AUPO879697A0 (en) 1997-08-27 1997-08-27 An intra-vaginal device
AUPO8796 1997-08-27
AU97/00186 1997-09-19
AUPO9323 1997-09-19
AUPO9323A AUPO932397A0 (en) 1997-09-19 1997-09-19 An intra-vaginal device
USPCTAU9800183 1998-03-20
PCT/AU1998/000183 WO1998042281A1 (en) 1997-03-20 1998-03-20 An intra-vaginal device
AU98/00183 1998-03-20

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/AU1998/000183 Continuation WO1998042281A1 (en) 1997-03-20 1998-03-20 An intra-vaginal device

Publications (2)

Publication Number Publication Date
US20020007106A1 true US20020007106A1 (en) 2002-01-17
US6413206B2 US6413206B2 (en) 2002-07-02

Family

ID=25645588

Family Applications (1)

Application Number Title Priority Date Filing Date
US09/197,736 Expired - Fee Related US6413206B2 (en) 1997-03-20 1998-11-20 Intra-vaginal device

Country Status (6)

Country Link
US (1) US6413206B2 (en)
EP (1) EP0923357B1 (en)
JP (1) JP2000510757A (en)
AT (1) ATE299357T1 (en)
AU (1) AU750463B2 (en)
WO (1) WO1998042281A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050027565A1 (en) * 2003-06-23 2005-02-03 John Sader Motivational method for helping substance abusers quit substance abuse
WO2012006670A1 (en) * 2010-07-13 2012-01-19 Contiform International Pty Ltd Intra-vaginal incontinence device and an applicator for same
US20220071800A1 (en) * 2015-08-20 2022-03-10 Watkins-Conti Products, Inc. Flexible cone-shaped intra-vaginal support device
EP2793779B1 (en) * 2011-12-20 2022-09-14 Kimberly-Clark Worldwide, Inc. Vaginal insert device having perpendicular segments

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6503190B1 (en) 2000-09-29 2003-01-07 Ethicon Endo-Surgery, Inc. Vaginal pessary
US6558370B2 (en) 2001-06-05 2003-05-06 Kimberly-Clark Worldwide, Inc. Urinary incontinence device
US6808485B2 (en) * 2002-12-23 2004-10-26 Kimberly-Clark Worldwide, Inc. Compressible resilient incontinence insert
JP2007529261A (en) 2004-03-18 2007-10-25 コンティピ リミテッド Female pelvic organ prolapse treatment device
ATE499902T1 (en) 2004-03-18 2011-03-15 Contipi Ltd DEVICE FOR PREVENTING URINARY INCONTINENCE IN WOMEN
MX345807B (en) 2005-03-17 2017-02-15 Kimberly-Clark Worldwide Inc * Apparatuses for the amelioration of urinary incontinence in females.
IL176883A (en) 2005-09-22 2013-09-30 Eliahu Eliachar Apparatus for the amelioration of urinary incontinence in females
US10004584B2 (en) 2006-07-10 2018-06-26 First Quality Hygienic, Inc. Resilient intravaginal device
US10219884B2 (en) 2006-07-10 2019-03-05 First Quality Hygienic, Inc. Resilient device
WO2008152628A1 (en) * 2007-06-11 2008-12-18 Contipi Ltd. Adjustable tension ring for amelioration of urinary incontinence in females
WO2009044394A2 (en) 2007-10-01 2009-04-09 Contipi Ltd. Management of urinary incontinence in females
US8651109B2 (en) 2008-04-23 2014-02-18 Contipi Ltd. Pessaries for prolapse alleviation
US20120271098A1 (en) 2009-11-24 2012-10-25 Elan Ziv Apparatuses for the treatment of urinary stress and urge incontinence
US9211211B2 (en) * 2010-02-02 2015-12-15 Neil Luke Maurette Female posterior wall prosthesis
US20120259163A1 (en) 2011-04-11 2012-10-11 Nancy Karapasha Method for treating urinary incontinence
US9078726B2 (en) 2011-04-11 2015-07-14 The Procter & Gamble Company Pessary device with longitudinal flexibility
US20150112231A1 (en) 2011-11-28 2015-04-23 Remendium Labs Llc Treatment of fecal incontinence
US9744630B2 (en) 2012-06-29 2017-08-29 The Procter & Gamble Company Method of conforming an overwrap to a pessary device
US11426625B2 (en) 2014-01-06 2022-08-30 Remendium Labs Llc System and method for optimizing pelvic floor muscle training
US10201411B2 (en) 2015-06-29 2019-02-12 The Procter & Gamble Company Pessary with applicator
BR112018002939A2 (en) 2015-08-12 2019-03-19 Innoventions Ltd system for treating a weak or leaking sphincter and system for inducing muscle tissue formation in an organ of the body
BR112019001393B1 (en) 2016-07-25 2023-04-25 Ovala, Inc INCONTINENCE DEVICE
ES2842380T3 (en) 2016-07-25 2021-07-13 Ovala Inc Incontinence device
SG11201900783PA (en) 2016-07-29 2019-02-27 Renovia Inc Devices, systems, and methods for training pelvic floor muscles
EP4074284A3 (en) 2017-01-24 2022-10-26 Liv Labs Inc. Stress urinary incontinence (sui) device
BR112019020676A2 (en) 2017-04-26 2020-05-12 Rinovum Subsidiary 2, LLC INTRODUCER OF URINARY INCONTINENCE DEVICE AND METHOD OF INTRODUCTION OF THE SAME
USD833009S1 (en) 2017-07-24 2018-11-06 Rinovum Subsidiary 2, LLC Incontinence device
USD832437S1 (en) 2017-07-24 2018-10-30 Rinovum Subsidiary 2, LLC Incontinence device
WO2019178570A1 (en) 2018-03-16 2019-09-19 Watkins-Conti Products, Inc. Intravaginal support devices and methods
USD888948S1 (en) * 2019-04-02 2020-06-30 Renovia Inc. Intravaginal device
USD888949S1 (en) * 2019-04-03 2020-06-30 Renovia Inc. Intravaginal device
USD898911S1 (en) 2019-04-03 2020-10-13 Renovia Inc. Intravaginal device assembly
USD889649S1 (en) * 2019-04-05 2020-07-07 Renovia Inc. Intravaginal device
USD896958S1 (en) * 2019-04-11 2020-09-22 Renovia Inc. Intravaginal device
USD899593S1 (en) * 2019-04-12 2020-10-20 Renovia Inc. Intravaginal device
USD896959S1 (en) * 2019-04-23 2020-09-22 Renovia Inc. Intravaginal device
USD897530S1 (en) * 2019-04-23 2020-09-29 Renovia Inc. Intravaginal device
WO2021142537A1 (en) 2020-01-14 2021-07-22 Cntrl+ Inc. Intravaginal device

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1790801A (en) * 1931-02-03 Louis dickstehst
US4139006A (en) * 1977-03-18 1979-02-13 Corey Arthur E Female incontinence device
US4920986A (en) 1986-10-14 1990-05-01 Zedlani Pty. Limited Urinary incontinence device
US5386836A (en) * 1986-10-14 1995-02-07 Zedlani Pty Limited Urinary incontinence device
DE3720858A1 (en) * 1987-06-24 1989-01-05 Thomas Moenks Device for the treatment of urinary incontinence in women
EP0460807A3 (en) * 1990-05-03 1992-01-08 Zedlani Pty. Limited Urinary incontinence device
FR2698781B1 (en) * 1992-12-07 1995-04-07 Chanez Jean Francois Device intended to remedy light urinary incontinence in women.
DK95193D0 (en) * 1993-08-20 1993-08-20 Coloplast As DEVELOPMENT TO PREVENT UNLOCKED WATER
US5609559A (en) * 1995-05-15 1997-03-11 Weitzner; Howard B. Device for female patients to prevent involuntary loss of urine
AU2019097A (en) * 1996-03-20 1997-10-10 Niquoola Pty. Ltd. An intra-vaginal device

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050027565A1 (en) * 2003-06-23 2005-02-03 John Sader Motivational method for helping substance abusers quit substance abuse
WO2012006670A1 (en) * 2010-07-13 2012-01-19 Contiform International Pty Ltd Intra-vaginal incontinence device and an applicator for same
EP2793779B1 (en) * 2011-12-20 2022-09-14 Kimberly-Clark Worldwide, Inc. Vaginal insert device having perpendicular segments
US20220071800A1 (en) * 2015-08-20 2022-03-10 Watkins-Conti Products, Inc. Flexible cone-shaped intra-vaginal support device

Also Published As

Publication number Publication date
EP0923357A4 (en) 2000-06-14
WO1998042281A9 (en) 1999-03-25
WO1998042281A1 (en) 1998-10-01
US6413206B2 (en) 2002-07-02
AU750463B2 (en) 2002-07-18
EP0923357A1 (en) 1999-06-23
ATE299357T1 (en) 2005-07-15
AU6604398A (en) 1998-10-20
EP0923357B1 (en) 2005-07-13
JP2000510757A (en) 2000-08-22

Similar Documents

Publication Publication Date Title
US6413206B2 (en) Intra-vaginal device
CA1322913C (en) Urinary incontinence device
US5386836A (en) Urinary incontinence device
US10405959B2 (en) Apparatus for the prevention of urinary incontinence in females
KR101040414B1 (en) C-shaped vaginal incontinence insert
US6189535B1 (en) Deflatable vaginal pessary
US20020083949A1 (en) Female incontinence control device
GR3031353T3 (en) Selective system scan for multizone radiotelephone subscriber units.
CA2477834A1 (en) Method and apparatus for treating pelvic organ prolapses in female patients
WO1997034550A1 (en) An intra-vaginal device
EP0460807A2 (en) Urinary incontinence device
MXPA98009687A (en) An intra-vaginal device
AU606408B2 (en) Female incontinence device
IL86078A (en) Urinary incontinence device
IE62880B1 (en) Urinary incontinence device
US20020166560A1 (en) Feminine urinary incontinence inhibitor interlabial device
NZ224254A (en) Intra-vaginal urinary incontinence control device
NZ222169A (en) Intra-vaginal, urinary incontinence control device

Legal Events

Date Code Title Description
AS Assignment

Owner name: NIQUOOLA PTY LTD, AUSTRALIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BISWAS, NICHOLAS;REEL/FRAME:009892/0998

Effective date: 19990316

REMI Maintenance fee reminder mailed
REIN Reinstatement after maintenance fee payment confirmed
FP Lapsed due to failure to pay maintenance fee

Effective date: 20060702

FEPP Fee payment procedure

Free format text: PETITION RELATED TO MAINTENANCE FEES FILED (ORIGINAL EVENT CODE: PMFP); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

FEPP Fee payment procedure

Free format text: PETITION RELATED TO MAINTENANCE FEES GRANTED (ORIGINAL EVENT CODE: PMFG); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

FPAY Fee payment

Year of fee payment: 4

SULP Surcharge for late payment
PRDP Patent reinstated due to the acceptance of a late maintenance fee

Effective date: 20080326

REMI Maintenance fee reminder mailed
FPAY Fee payment

Year of fee payment: 8

SULP Surcharge for late payment

Year of fee payment: 7

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20140702